TOPIC INTRODUCTION

Bill C-224, the Natural Health Products regulatory framework, seeks to modernize oversight of supplements, traditional medicines, and complementary therapies in Canada. Proponents argue it enhances consumer safety and transparency, while critics warn it risks overburdening small businesses and stifling innovation. The debate hinges on whether this narrow regulatory intervention addresses real public health needs or merely masks deeper systemic issues.

Key Tensions:

Bill C-224: An Act to amend the Food and Drugs Act (natural health products)

Bill C-224 — 45-1